Validation of lymphatic mapping and sentinel node biopsy in patients with symptomatic breast cancer

被引:3
作者
Cahill, R. A.
Diamond, L.
Landers, R.
Walsh, D.
Watson, R. G. K.
机构
[1] Waterford Reg Hosp, Breast Care Unit, Dept Surg Radiol & Nucl Med, Waterford, Ireland
[2] Waterford Reg Hosp, Breast Care Unit, Dept Pathol, Waterford, Ireland
关键词
D O I
10.1007/BF03167952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lymphatic mapping and sentinel node biopsy in breast cancer aims to allow lymph node negative women to avoid axillary clearance by providing a minimally invasive means of staging the axilla. However, before its implementation into routine clinical practice, initiating departments must verify their expertise in each of the surgical, radiological and pathological components necessary for its successful performance. Here, we present our validation experience. Methods Thirty patients with breast cancer of any stage (but without clinical axillary lymphadenopathy) undergoing definitive resection of their primary tumour underwent lymphatic mapping (using blue dye alone or in combination with radioisotope) and sentinel node biopsy concurrent with standard level II axillary clearance over a ten month period. Results All patients had sentinel nodes identified intraoperatively. The sentinel node in 29 patients correctly predicted the status of axillary involvement. One patient had non-sentinel nodal disease without metastases being identified in their sentinel node. Such a single false negative out of thirty patients is considered acceptable by current guidelines. Conclusion Validation of expertise in sentinel node identification and analysis is feasible over a relatively short period of time in a regional symptomatic breast unit. We now feel confident in offering this procedure to selected patients with breast cancer in our catchment area in place of routine axillary clearance.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 15 条
  • [1] Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer
    Beenken, SW
    Urist, MM
    Zhang, YT
    Desmond, R
    Krontiras, H
    Medina, H
    Bland, KI
    [J]. ANNALS OF SURGERY, 2003, 237 (05) : 732 - 738
  • [2] BLANCHARD DK, 2001, ARCH SURG-CHICAGO, V138, P482
  • [3] Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer
    de Kanter, AY
    van Eijck, CHJ
    van Geel, AN
    Kruijt, RH
    Henzen, SC
    Paul, MA
    Eggermont, AMM
    Wiggers, T
    [J]. BRITISH JOURNAL OF SURGERY, 1999, 86 (11) : 1459 - 1462
  • [4] Axillary dissection in the context of the biology of lymph node metastases
    Gervasoni, JE
    Taneja, C
    Chung, MA
    Cady, B
    [J]. AMERICAN JOURNAL OF SURGERY, 2000, 180 (04) : 278 - 283
  • [5] Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes
    Guenther, JM
    Hansen, NM
    DiFronzo, LA
    Giuliano, AE
    Collins, JC
    Grube, BL
    O'Connell, TX
    [J]. ARCHIVES OF SURGERY, 2003, 138 (01) : 52 - 56
  • [6] Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer
    Karamlou, T
    Johnson, NM
    Chan, B
    Franzini, D
    Mahin, D
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 185 (05) : 425 - 428
  • [7] Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer
    Mullenix, PS
    Carter, PL
    Martin, MJ
    Steele, SK
    Scott, CL
    Walts, MJ
    Beitler, AL
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 185 (05) : 420 - 424
  • [8] Is lymphatic mapping in breast cancer adequate and safe?
    Nieweg, OE
    Rutgers, EJT
    Jansen, L
    Olmos, RAV
    Peterse, JL
    Hoefnagel, KA
    Kroon, BBR
    [J]. WORLD JOURNAL OF SURGERY, 2001, 25 (06) : 780 - 788
  • [9] Sentinel lymph node biopsy and breast cancer
    Noguchi, M
    [J]. BRITISH JOURNAL OF SURGERY, 2002, 89 (01) : 21 - 34
  • [10] NUGENT N, IR J MED SCI, V4, P236